MedPath

Assessment of the Effects of Postbiotic Supplementation with Lactobacillus rhamnosus CRL 1505 and Lactobacillus johnsonii La1 (La1), with a Focus on Interleukin 10 ; Impact on Upper Respiratory Tract Infection and vaginitis Incidence.

Not Applicable
Conditions
Condition 1: upper respiratory tract infection. Condition 2: vaginitis.
Acute upper respiratory infection, unspecified
Acute vaginitis
J06.9
N76.0
Registration Number
IRCT20100119003106N48
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
150
Inclusion Criteria

adult men or women between 18 and 65 years old who enter the study and have fully understood the risks and potential benefits of participating in the study
and before entering the study, consent forms They have signed it knowingly.

Exclusion Criteria

Unwillingness to continue or participate in the study
Diagnosis of immunodeficiency due to any diagnosed chronic disease
Gastrointestinal ulcer
Liver and kidney dysfunction
Human immunodeficiency virus
Autoimmune disorders
Malignancy, or any history of malignancy
Any diagnosis of respiratory diseases with cold or flu-like symptoms
Severe diseases such as asthma and severe allergies
Pregnancy, breastfeeding
Drug or alcohol addiction
Taking any immunosuppressants or immunomodulators

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath